| ClinicalTrials.gov Identifier: |
NCT01495702 |
| Brief Title: |
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients |
|
|
First Submitted : |
December 14, 2011 |
|
First Submitted that Met QC Criteria : |
December 16, 2011 |
|
First Posted : |
December 20, 2011
(Estimate)
|
|
|
Results First Submitted : |
December 31, 2014 |
|
Results First Submitted that Met QC Criteria : |
January 22, 2015 |
|
Results First Posted : |
January 26, 2015
(Estimate)
|
|
|
Certification/Extension First Submitted : |
August 25, 2014 |
|
Certification/Extension First Submitted that Met QC Criteria : |
August 25, 2014 |
|
Certification/Extension First Posted : |
August 27, 2014
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
December 1, 2015 |
|
Last Update Posted : |
January 7, 2016
(Estimate)
|
|
